Advanced search
Publication Cover
Leukemia & Lymphoma Volume 45, 2004 - Issue 1
Submit an article Journal homepage
28
Views
12
CrossRef citations to date
0
Altmetric
Original Article

Hematopoietic Recovery Following Induction Therapy of Acute Leukemias: Prognostic Implications and a New Look at the Definition of Remission

STEFAN FADERL Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USACorrespondence[email protected]
&
ZEEV ESTROV Department of Bioimmunotherapy, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA
Pages 67-71 | Received 20 May 2003, Published online: 03 Aug 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Yuefang Wang, Ge Zhang, Lei Ye, Qingkai Dai, Luyun Peng, Lan Chen, Qi Chen, Yongmei Jiang & Ju Gao. (2019) Clinical value of the quantitation of average daily platelet increase during the recovery period in childhood acute lymphoblastic leukaemia. Platelets 30:7, pages 923-926.
Read now
Julie Dalsgaard Grunnan & Steen Rosthøj. (2019) Time course of peripheral blood count recovery during induction chemotherapy for childhood acute lymphoblastic leukemia. Hematology 24:1, pages 467-472.
Read now

Articles from other publishers (10)

Mahdieh Mehrpouri. (2022) The contributory roles of the CXCL12/CXCR4/CXCR7 axis in normal and malignant hematopoiesis: A possible therapeutic target in hematologic malignancies. European Journal of Pharmacology 920, pages 174831.
Crossref
Qingkai Dai, Rui Shi, Ge Zhang, Hui Yang, Yuefang Wang, Lei Ye, Luyun Peng, Siqi Guo, Jiajing He & Yongmei Jiang. (2021) Combined use of peripheral blood blast count and platelet count during and after induction therapy to predict prognosis in children with acute lymphoblastic leukemia. Medicine 100:15, pages e25548.
Crossref
Wen Yao, Xiandeng CHU, Xinchen Fang, Xiaoyu Zhu, Baolin Tang, Xiang Wan, Liangquan Geng, Juan Tong, Kaidi Song, Xuhan Zhang, Ping Qiang, Guangyu Sun, Huilan Liu & Zimin Sun. (2020) Decitabine prior to salvaged cord blood transplantation for acute myeloid leukaemia/myelodysplastic syndrome not in remission. Journal of Clinical Pharmacy and Therapeutics 45:6, pages 1372-1381.
Crossref
Hongyu Zhao, Li Xu, Yongjian Yang, Jianhua Shao, Ping Chen, Xuebin Dong, Linping Gu & Daqi Li. (2017) Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia. Acta Haematologica 137:4, pages 195-200.
Crossref
Yuping Cheng, Zebin Luo, Shilong Yang, Ming Jia, Haizhao Zhao, Weiqun Xu & Yongmin Tang. (2015) The ratio of absolute lymphocyte count at interim of therapy to absolute lymphocyte count at diagnosis predicts survival in childhood B-lineage acute lymphoblastic leukemia. Leukemia Research 39:2, pages 144-150.
Crossref
Joseph M. Scandura, Gail J. Roboz, Michelle Moh, Ewelina Morawa, Fabienne Brenet, J. Robi Bose, Luis Villegas, Usama S. Gergis, Sebastian A. Mayer, Cindy M. Ippoliti, Tania J. Curcio, Ellen K. Ritchie & Eric J. Feldman. (2011) Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML. Blood 118:6, pages 1472-1480.
Crossref
TAMER H. HASSAN. (2011) Early chemosensitivity of normal hematopoietic cells and malignant lymphoblasts predicts relapse in childhood acute lymphoblastic leukemia. Oncology Letters 2:1, pages 139-144.
Crossref
Guillermo De Angulo, Carrie Yuen, Shana L. Palla, Peter M. Anderson & Patrick A. Zweidler-McKay. (2008) Absolute lymphocyte count is a novel prognostic indicator in ALL and AML. Cancer 112:2, pages 407-415.
Crossref
I. W. Blau, Martin Schmidt-Hieber, N. Leschinger, H. Göldner, W. Knauf, W. Hopfenmüller, E. Thiel & O. Blau. (2007) Engraftment kinetics and hematopoietic chimerism after reduced-intensity conditioning with fludarabine and treosulfan before allogeneic stem cell transplantation. Annals of Hematology 86:8, pages 583-589.
Crossref
. (2004) Current Awareness in Hematological Oncology. Hematological Oncology 22:2, pages 73-84.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.